D. Western Therapeutics Institute, Inc. (4576.T) Comparison with companies in other sectors?

D. Western Therapeutics Institute, Inc. has a share price of 45.74M. You can analyze D. Western Therapeutics Institute, Inc. (4576.T) competitors across different market sectors through stock heatmaps.

What are 4576.T's NET and operating margins?

D. Western Therapeutics Institute, Inc. (4576.T) operating margin is around -2.23, and net profit margin is approximately -2.42 as of the latest reports.

In what way does 4576.T's earnings per share (EPS) trend reflect its financial momentum?

D. Western Therapeutics Institute, Inc. (4576.T) EPS is -36.74 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for D. Western Therapeutics Institute, Inc. is -3.05, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for D. Western Therapeutics Institute, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for D. Western Therapeutics Institute, Inc. like P/E which is -4.40, P/B which is 4.92, and PEG which is -0.24. Compare them with sector averages to evaluate if the stock is priced fairly.

D. Western Therapeutics Institute, Inc.

4576.T•JPX

Healthcare

Biotechnology

¥112.00

¥-2.00(-1.75%)

D. Western Therapeutics Institute, Inc. (4576.T) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-36.74

P/E Ratio

-3.05

ROE

-1.24%

Net Margin

-2.42%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.12B

Shares OutstandingTotal number of shares issued

$45.74M

Book Value/ShareNet worth per share

$22.76

Revenue/ShareAnnual revenue per share

$10.54

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-36.74

Net MarginNet income as percentage of revenue

-241.55%

Operating MarginOperating income as percentage of revenue

-222.82%

ROEReturn on shareholders' equity

-124.03%

ROAReturn on total assets

-69.97%

ROCEReturn on capital employed

-68.08%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$25.94

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 4576.TFinancial Ratios Analysis details for 4576.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 4576.TSector Benchmarking details for 4576.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for D. Western Therapeutics Institute, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of D. Western Therapeutics Institute, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account D. Western Therapeutics Institute, Inc.'s unique business strengths and challenges.

Key Financial Metrics for D. Western Therapeutics Institute, Inc.

For D. Western Therapeutics Institute, Inc., essential financial indicators include EPS -36.74, PE -3.05, and ROE -1.24. These key ratios reveal insights into D. Western Therapeutics Institute, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare D. Western Therapeutics Institute, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of D. Western Therapeutics Institute, Inc.

Metrics like Net Margin -241.55% and ROA -69.97% shed light on how well D. Western Therapeutics Institute, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether D. Western Therapeutics Institute, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of D. Western Therapeutics Institute, Inc.

Using ratios such as P/B Ratio 4.92 and PEG Ratio -0.24, investors can assess whether D. Western Therapeutics Institute, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with D. Western Therapeutics Institute, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for D. Western Therapeutics Institute, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.51 and Cash Flow -, provide a snapshot of D. Western Therapeutics Institute, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like D. Western Therapeutics Institute, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for D. Western Therapeutics Institute, Inc.

Investing in D. Western Therapeutics Institute, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at D. Western Therapeutics Institute, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;